Activation of STAT3 results from the binding of cmvIL10 to the IL-10 receptor [74,75,76,77], and has been described in breast cancer, ovarian cancer with poor prognosis, and to increase the spread of glioma cancer stem cells in malignant glioma [78,79,80]. Here, STAT3 is linked to breast cancer.